Joseph M. Manko Jr. bought $174k of MYO
director at MYOMO, INC.. 201,197 shares at an average of $0.86, traded May 14, 2026, filed May 18, 2026.
Score components
- +15RoleDirector
- +11Trade size$174k at market
- +3Relative to holdingsHoldings up 10%
- +8Price context75% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001664091-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 14, 2026 | POpen-market purchase MYOindirect: By Horton Capital Partners Fund, LP (1) | +170,830 | $0.86 | $147k | 2,279,408 | May 18, 2026 |
| May 15, 2026 | POpen-market purchase MYOindirect: By Horton Capital Partners Fund, LP (1) | +30,367 | $0.89 | $27k | 2,309,775 | May 18, 2026 |
Related signals
Other insiders at MYOMO, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $20k 15,488 shares | -15% | |
| 23Weak | MYOMO, INC. | Milton Mayo Morris director | $21k 15,000 shares | -7% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $30k 17,500 shares | -14% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $30k 17,250 shares | -14% | |
| 33Weak | MYObuy MYOMO, INC. | Thomas F Kirk director | $51k 40,002 shares | +6% | |
| 42Moderate | MYOMO, INC. | Micah Mitchell Chief Commercial Officer | $78k 90,231 shares | -45% | |
| 31Weak | MYOMO, INC. | Thomas F Kirk director | $25k 25,000 shares | +4% | |
| 33Weak | MYOMO, INC. | Harry Kovelman Chief Medical Officer | $32k 32,000 shares | -23% | |
| 42Moderate | MYOMO, INC. | Thomas F Kirk director | $68k 75,006 shares | +14% | |
| 34Weak | MYOsell MYOMO, INC. | Micah Mitchell Chief Commercial Officer | $78k 90,231 shares | -45% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.